Clinical Trials Browser

INDIV × Interventional × Bevacizumab × Clear all

NCT00775073 2012-04-30

Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms